Samsung BioLogics Co., Ltd.

https://www.samsungbiologics.com

Samsung Biologics is a fully integrated CDMO offering state-of-the-art contract development, manufacturing, and analytical testing services. With a proven regulatory approvals record, the largest capacity, and the fastest throughput, Samsung Biologics is an award-winning partner of choice and is uniquely able to support the development and manufacturing of biologics products at every stage of the process while meeting the evolving needs of biopharmaceutical companies worldwide. *

	Start	2013-10-23 existent
	Industry	contract manufacturing (biologicals)
	Person	Kim, Tae-Han (Samsung 201205– CEO of Samsung BioLogics)

	Region	Seoul
	Country	Korea, Republic of
	Street	Seocho 2-dong, 27F, 1320-10 Seocho-gu
	City	137-965 Seoul
	Tel	+82-2-2255-8500
		Address record changed: 2020-12-02

Basic data	Employees	n. a.

		* Document for »About Section«: GlaxoSmithKline plc. (5/21/20). "Press Release: GSK Partners with Samsung Biologics to Secure Additional Manufacturing Capacity for Innovative Biopharmaceutical Portfolio". London & Songdo.

		Record changed: 2023-07-10